SARS-CoV-2 antigen testing: weighing the false positives against the costs of failing to control transmission.
Fearon, E
; Buchan, IE; Das, R; Davis, EL; Fyles, M; Hall, I; Hollingsworth, TD; House, T; Jay, C; Medley, GF; +5 more...Pellis, L; Quilty, BJ; Silva, ME; Stage, HB; Wingfield, T and
(2021)
SARS-CoV-2 antigen testing: weighing the false positives against the costs of failing to control transmission.
Lancet Respiratory Medicine, 9 (7).
pp. 685-687.
ISSN 2213-2600
DOI: 10.1016/S2213-2600(21)00234-4
; Buchan, IE; Das, R; Davis, EL; Fyles, M; Hall, I; Hollingsworth, TD; House, T; Jay, C; Medley, GF; +5 more...Pellis, L; Quilty, BJ; Silva, ME; Stage, HB; Wingfield, T and
(2021)
SARS-CoV-2 antigen testing: weighing the false positives against the costs of failing to control transmission.
Lancet Respiratory Medicine, 9 (7).
pp. 685-687.
ISSN 2213-2600
DOI: 10.1016/S2213-2600(21)00234-4
-
picture_as_pdf - LFD_false_positives_6may.pdf
-
subject - Accepted Version
-
- Available under Creative Commons: Attribution-NonCommercial-No Derivative Works 3.0
Downloads